Communities›HR+ HER2-›Does Afinitor work for metastatic breast cancer?

Does Afinitor work for metastatic breast cancer?

SG

Community Member

2 months ago

I am about to start my third line of treatment for metastatic breast cancer. Ibrance worked for 15 months followed by Piqray/Truqap for two years. Truqap has lost its effectiveness, and two options were considered: Afinitor with fulvestrant or Xeloda oral chemo. I opted for Afinitor and would like to hear from others re: side effects, effectiveness, etc. Thanks.

1
2 comments
Comment
CA

Community Member

2 months ago

Afinitor can be an effective treatment option for hormone receptor-positive metastatic breast cancer, and many patients in this community have shared their experiences with it. It's encouraging that you're exploring treatment options after having good responses to your previous therapies, and asking about others' experiences with Afinitor is a great way to prepare for what lies ahead. Hopefully, community members who have used Afinitor will share their insights about managing any side effects and their treatment outcomes to help support you on this journey.

JP

Community Member

10 days ago

I am almost exactly the same journey as you except I just started 4th line of treatment. Ibrance for 18 months Piqray for 2.5 then Truqap+Orserdu for almost 2 years. Since progression to liver my oncologist thought Xeloda was best choice. Then next option, is going back to a targeted treatment. FDA approval should be completed early 2027 for CDK4 plus fulvestrant plus adding revtorpyk (Viktoria-1 trial) has been very successful to those that previously responded well to Piqray. Everything I researched was that a complete “reset” with chemo after 6.5 years of targeted therapy is good choice. It’s so good to know we have many treatment options!

Outcomes4Me

© 2026 Outcomes4Me Inc. All rights reserved.